First Trust Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.22M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $1.63M | Buy |
|
|||||
|
2024
Q2 | $2.25M | Buy |
|
|||||
|
2024
Q1 | $1.01M | Sell |
|
|||||
|
2023
Q4 | $1.56M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $542K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $1.41M | Sell |
|
|||||
|
2022
Q3 | $2.97M | Sell |
|
|||||
|
2022
Q2 | $4.16M | Buy |
|
|||||
|
2022
Q1 | $2.66M | Buy |
|
|||||
|
2021
Q4 | $847K | Buy |
|
|||||
|
2021
Q3 | $310K | Sell |
|
|||||
|
2021
Q2 | $1.73M | Buy |
|
|||||
|
2021
Q1 | $1.37M | Sell |
|
|||||
|
2020
Q4 | $2.64M | Sell |
|
|||||
|
2020
Q3 | $3.01M | Buy |
|
|||||
|
2020
Q2 | $2.46M | Buy |
|
|||||
|
2020
Q1 | $1.12M | Buy |
|
|||||
|
2019
Q4 | $1.33M | Sell |
|
|||||
|
2019
Q3 | $2.4M | Buy |
|
|||||
|
2019
Q2 | $582K | Sell |
|
|||||
|
2019
Q1 | $2.62M | Sell |
|
|||||
|
2018
Q4 | $3.47M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $584K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $1.7M | Sell |
|
|||||
|
2014
Q3 | $1.87M | Buy |
|
|||||
|
2014
Q2 | $1.61M | Buy |
|